SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-303072
Filing Date
2021-10-20
Accepted
2021-10-20 16:19:57
Documents
12
Period of Report
2021-10-20
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K d195018d8k.htm   iXBRL 8-K 23488
  Complete submission text file 0001193125-21-303072.txt   149428

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crnx-20211020.xsd EX-101.SCH 2896
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20211020_lab.xml EX-101.LAB 18889
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20211020_pre.xml EX-101.PRE 11863
5 EXTRACTED XBRL INSTANCE DOCUMENT d195018d8k_htm.xml XML 3486
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 211334428
SIC: 2834 Pharmaceutical Preparations